COMMUNIQUÉS West-GlobeNewswire

HEXO Supports Privatization of Retail Cannabis in Ontario

27/07/2018 - 19:20

GATINEAU, Quebec, July 27, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to hear reports that the Ontario government is considering the privatization of adult- [...]

HEXO appuie la privatisation des ventes au détail du cannabis en Ontario

27/07/2018 - 19:20

GATINEAU, Québec, 27 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) est heureuse d’apprendre que le gouvernement de l’Ontario envisage la privatisation de la vente au [...]

INSYS Therapeutics Receives Complete Response Letter from FDA for Buprenorphine NDA

27/07/2018 - 18:50

PHOENIX, July 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) announced that today it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company [...]

Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split

27/07/2018 - 17:58

EXTON, Pa., July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]

CASMED to Report Second-Quarter 2018 Financial Results and Hold Conference Call on August 2

27/07/2018 - 17:12

BRANFORD, Conn., July 27, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED) , a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results [...]

The American Health Council Board of Nurses Welcomes Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME

27/07/2018 - 17:11

NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The American Health Council is proud to appoint Sarah Kavalauskas MSN, BSN, RN, PALS, ACLS, NRCME to its Board of Nurses. Currently a Certified Nurse Practitioner at Health [...]

Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018

27/07/2018 - 17:10

EAST RUTHERFORD, N.J., July 27, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]

Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

27/07/2018 - 17:05

IRVING, Texas, July 27, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of its previously announced [...]

Lotus Facility Construction & Commissioning Update

27/07/2018 - 17:01

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 27, 2018 (GLOBE NEWSWIRE) -- ARMSTRONG FACILITY Construction of Lotus’ initial production [...]

MannKind and Tanner Pharma Group Enter into an ex-U.S. Distribution Agreement for Afrezza®

27/07/2018 - 15:37

WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]

Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA™ (Pegfilgrastim Biosimilar Candidate)

27/07/2018 - 15:36

REDWOOD CITY, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has [...]

MannKind Corporation to Hold 2018 Second Quarter Financial Results Conference Call on August 2, 2018

27/07/2018 - 15:00

WESTLAKE VILLAGE, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will host a conference call to discuss the 2018 second quarter and year-to-date financial results and other corporate [...]

Aeroponics Can Change Cannabis Cultivation -- CFN Media

27/07/2018 - 15:00

SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

BlissCo Advances E-Commerce Program Ahead of Cannabis Legalization -- CFN Media

27/07/2018 - 15:00

SEATTLE, July 27, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]

ContraFect Corporation Prices $10 Million Public Offering of Common Stock

27/07/2018 - 15:00

YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]

BioCryst to Announce Second Quarter 2018 Financial Results on August 7

27/07/2018 - 15:00

RESEARCH TRIANGLE PARK, N.C., July 27, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that its second quarter 2018 financial results will be reported on Tuesday, August 7, 2018. [...]

Sandoz receives European Commission approval for biosimilar Hyrimoz® (adalimumab)

27/07/2018 - 14:54

Biosimilar Hyrimoz ® (adalimumab) approved for use in all same indications as reference medicine ** * including rheumatology, gastroenterology and dermatology Early therapeutic intervention is essential in rheumatoid [...]

Curriculum Vitae of Lauris Macijevskis a newly elected Board member of AS Olainfarm

27/07/2018 - 14:45

CURRICULUM VITAE of Lauris Macijevskis Name, Surname: Lauris Macijevskis Education: 2004 - 2006 Riga International School of Economics and Business Administration, diploma for higher professional education - Master in [...]

Cellectar Biosciences Announces Pricing of $14.4 Million Underwritten Public Offering

27/07/2018 - 14:30

MADISON, Wis., July 27, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB) (“Cellectar” or the “Company”), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization [...]